MyAverix Finance
F · Healthcare
Corbus Pharmaceuticals Holdings, Inc. (3371)
Biotechnology
Corbus Pharmaceuticals Holdings, Inc. (3371) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3371
Corbus Pharmaceuticals Holdings, Inc. (3371) — FAQ
What is 3371's P/E ratio?
The price-to-earnings (P/E) ratio for Corbus Pharmaceuticals Holdings, Inc. (3371) is 25.00 (data as of 2026-05-23).
Does Corbus Pharmaceuticals Holdings, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Corbus Pharmaceuticals Holdings, Inc. (3371). Check the MyAverix Finance app for the latest dividend data.
What sector is Corbus Pharmaceuticals Holdings, Inc. in?
Corbus Pharmaceuticals Holdings, Inc. (3371) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3371 listed on?
3371 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.